Riyas Fadal - Ascendis Health Chief Officer
| ASC Stock | 90.00 12.00 15.38% |
Executive
Riyas Fadal is Chief Officer of Ascendis Health
| Age | 48 |
| Phone | 27 11 036 9600 |
| Web | https://www.ascendishealth.com |
Ascendis Health Management Efficiency
Ascendis Health's management efficiency ratios could be used to measure how well Ascendis Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Tobie Krige | Adcock Ingram Holdings | N/A | |
| Nkosinathi Mthethwa | Adcock Ingram Holdings | N/A | |
| BCompt RA | African Media Entertainment | 48 | |
| Vosloo | Afine Investments | N/A | |
| Gaynor Poretti | Avi | 54 | |
| Rivak Bunce | African Media Entertainment | 61 | |
| Roger Coppin | Avi | 62 | |
| Stavros Nicolaou | Aspen Pharmacare Holdings | 58 | |
| Dip MBA | Aspen Pharmacare Holdings | 48 | |
| Lorraine Hill | Aspen Pharmacare Holdings | 59 | |
| Carnie Linde | Aspen Pharmacare Holdings | 54 | |
| ACIS BProc | Aspen Pharmacare Holdings | 47 | |
| Vivien Crystal | Avi | 62 | |
| NDip MBA | Adcock Ingram Holdings | N/A | |
| Mahlatse Phalafala | Adcock Ingram Holdings | N/A | |
| Trevor Ziman | Aspen Pharmacare Holdings | 51 | |
| Zizipho Mmango | Aspen Pharmacare Holdings | 38 | |
| John JankovichBesan | Avi | 55 | |
| BCom BCom | Aspen Pharmacare Holdings | 62 | |
| BCom Pharm | Adcock Ingram Holdings | N/A | |
| Jaco Dauth | Argent | N/A | |
Management Performance
| Return On Equity | -1.66 | |||
| Return On Asset | -0.0068 |
Ascendis Health Leadership Team
Elected by the shareholders, the Ascendis Health's board of directors comprises two types of representatives: Ascendis Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ascendis. The board's role is to monitor Ascendis Health's management team and ensure that shareholders' interests are well served. Ascendis Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ascendis Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Riyas Fadal, Chief Officer | ||
| LeeAnn Herbst, Managing SA | ||
| Chris Swanepoel, Managing Devices | ||
| Carl Neethling, Chief CEO | ||
| Marnus Sonnekus, Managing Pharma |
Ascendis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ascendis Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.66 | |||
| Return On Asset | -0.0068 | |||
| Profit Margin | 0.29 % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 762.19 M | |||
| Shares Outstanding | 487.45 M | |||
| Shares Owned By Insiders | 41.03 % | |||
| Shares Owned By Institutions | 25.00 % | |||
| Price To Book | 0.82 X | |||
| Price To Sales | 0.21 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ascendis Stock
Ascendis Health financial ratios help investors to determine whether Ascendis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ascendis with respect to the benefits of owning Ascendis Health security.